MDLNMedline Inc.

The four financial statements

Every company that sells shares in the US files four statements with the SEC. Together they show whether Medline made money, what it owns and owes, where its cash went, and what changed for its shareholders. Below is every line exactly as Medline filed it, with what each one means in plain English.

As filed with the SEC on Feb 25, 2026 · the full report · SEC's figures viewer

Income statement · also called the statement of operations, statement of earnings or profit and loss

Did it make money?

Read it from the top down. It starts with everything customers paid (sales), takes away the cost of making what was sold, then the costs of running the company, then interest and tax. What is left at the bottom is profit (net income), the part that belongs to shareholders. It covers a stretch of time: a year, or a quarter.

People usually check: Are sales growing compared with a year earlier?
People usually check: How much of each dollar of sales is left at each step (the margins)?
People usually check: Is profit growing faster or slower than sales?

This yearly report doesn't include a separate income statement in its tagged data.

Extra: What other gains and losses were there?Statement of comprehensive income: Profit, plus gains and losses that skip the income statement.

Some value changes don't count as profit yet: currency moves on businesses abroad, rises or falls in investments it hasn't sold, and some hedges and pension changes. They are added to profit here to give comprehensive income, and they build up in shareholders' equity.

Every line, explained

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME, every line
Line (tap for what it means)	12 months to Dec 31, 2025	12 months to Dec 31, 2024	12 months to Dec 31, 2023
Income Statement
	$28.4B	$25.5B	$23.2B
	$20.9B	$18.5B	$17.3B
	$7.5B	$7.0B	$5.9B
Operating expense
	$4.5B	$4.1B	$3.9B
	$704.0M	$685.0M	$662.0M
	$78.0M	$37.0M	$106.0M
	$5.3B	$4.8B	$4.6B
	$2.2B	$2.1B	$1.3B
Other expense
	−$812.0M	−$864.0M	−$976.0M
	−$64.0M	−$43.0M	$1.0M
	−$88.0M	$7.0M	−$11.0M
	−$964.0M	−$900.0M	−$986.0M
	$1.2B	$1.2B	$264.0M
	$91.0M	$46.0M	$30.0M
	$1.2B	$1.2B	$234.0M
	−$2.0M	–	–
	$1.2B	–	–
Net loss per share attributable to Medline Inc.
	−$0.01	–	–
	−$0.01	–	–
Weighted average number of Class A common shares outstanding
	810.0M shares	–	–
	810.0M shares	–	–
Other comprehensive income (loss), net of tax
	−$8.0M	$0	−$2.0M
	−$89.0M	−$88.0M	−$115.0M
	$129.0M	−$89.0M	$43.0M
	$32.0M	−$177.0M	−$74.0M
	$1.2B	$1.0B	$160.0M
	−$2.0M	$0	$0
	$1.2B	$1.0B	$160.0M

Opening its latest reports…Reading every line of the four statements…Putting it into plain words…

Did it make money?

People usually check: Are sales growing compared with a year earlier?

People usually check: How much of each dollar of sales is left at each step (the margins)?

People usually check: Is profit growing faster or slower than sales?

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME, every line
Line (tap for what it means)	12 months to Dec 31, 2025	12 months to Dec 31, 2024	12 months to Dec 31, 2023
Income Statement
	$28.4B	$25.5B	$23.2B
	$20.9B	$18.5B	$17.3B
	$7.5B	$7.0B	$5.9B
Operating expense
	$4.5B	$4.1B	$3.9B
	$704.0M	$685.0M	$662.0M
	$78.0M	$37.0M	$106.0M
	$5.3B	$4.8B	$4.6B
	$2.2B	$2.1B	$1.3B
Other expense
	−$812.0M	−$864.0M	−$976.0M
	−$64.0M	−$43.0M	$1.0M
	−$88.0M	$7.0M	−$11.0M
	−$964.0M	−$900.0M	−$986.0M
	$1.2B	$1.2B	$264.0M
	$91.0M	$46.0M	$30.0M
	$1.2B	$1.2B	$234.0M
	−$2.0M	–	–
	$1.2B	–	–
Net loss per share attributable to Medline Inc.
	−$0.01	–	–
	−$0.01	–	–
Weighted average number of Class A common shares outstanding
	810.0M shares	–	–
	810.0M shares	–	–
Other comprehensive income (loss), net of tax
	−$8.0M	$0	−$2.0M
	−$89.0M	−$88.0M	−$115.0M
	$129.0M	−$89.0M	$43.0M
	$32.0M	−$177.0M	−$74.0M
	$1.2B	$1.0B	$160.0M
	−$2.0M	$0	$0
	$1.2B	$1.0B	$160.0M

Line (tap for what it means)

12 months to Dec 31, 2025

12 months to Dec 31, 2024

12 months to Dec 31, 2023

Income Statement

$28.4B

$25.5B

$23.2B

$20.9B

$18.5B

$17.3B

$7.5B

$7.0B

$5.9B

Operating expense

$4.5B

$4.1B

$3.9B

$704.0M

$685.0M

$662.0M

$78.0M

$37.0M

$106.0M

$5.3B

$4.8B

$4.6B

$2.2B

$2.1B

$1.3B

Other expense

−$812.0M

−$864.0M

−$976.0M

−$64.0M

−$43.0M

$1.0M

−$88.0M

$7.0M

−$11.0M

−$964.0M

−$900.0M

−$986.0M

$1.2B

$264.0M

$91.0M

$46.0M

$30.0M

$1.2B

$234.0M

−$2.0M

–

$1.2B

–

Net loss per share attributable to Medline Inc.

−$0.01

–

−$0.01

–

Weighted average number of Class A common shares outstanding

810.0M shares

–

810.0M shares

–

Other comprehensive income (loss), net of tax

−$8.0M

−$2.0M

−$89.0M

−$88.0M

−$115.0M

$129.0M

−$89.0M

$43.0M

$32.0M

−$177.0M

−$74.0M

$1.2B

$1.0B

$160.0M

−$2.0M

$1.2B

$1.0B

$160.0M